Differential effect of erythropoietin and carbamylated erythropoietin on endothelial cell migration
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier Ltd
2017
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 16292caa a22015617a 4500 | ||
|---|---|---|---|
| 001 | PAPER-15073 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204543.0 | ||
| 008 | 190410s2017 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-85011818888 | |
| 024 | 7 | |2 cas |a calcium, 7440-70-2, 14092-94-5; erythropoietin, 11096-26-7; nitric oxide, 10102-43-9; recombinant erythropoietin, 113427-24-0, 122312-54-3, 130455-76-4, 879555-13-2, 148363-16-0, 154725-65-2; carbamylated erythropoietin; Erythropoietin; Nitric Oxide; Protein Tyrosine Phosphatase, Non-Receptor Type 1; PTPN1 protein, human; Reactive Oxygen Species | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a IJBBF | ||
| 100 | 1 | |a Maltaneri, R.E. | |
| 245 | 1 | 0 | |a Differential effect of erythropoietin and carbamylated erythropoietin on endothelial cell migration |
| 260 | |b Elsevier Ltd |c 2017 | ||
| 270 | 1 | 0 | |m Vittori, D.C.; Universidad de Buenos Aires, Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Pabellón II, Piso 4, Argentina; email: dvittori@qb.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Aicher, A., Heeschen, C., Mildner-Rihm, C., Urbich, C., Ihling, C., Technau-Ihling, K., Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells (2003) Nat. Med., 9, pp. 1370-1376 | ||
| 504 | |a Albini, A., Morini, M., Agostini, F.D., Ferrari, N., Campelli, F., Arena, G., Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice (2001) Cancer Res., 61, pp. 8171-8178 | ||
| 504 | |a Anagnostou, A., Lee, E.S., Kessimian, N., Levinson, R., Steiner, M., Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells (1990) Proc. Natl. Acad. Sci. U. S. A., 87, pp. 5978-5982 | ||
| 504 | |a Anagnostou, A., Liu, Z., Steiner, M., Chin, K., Lee, E.S., Kessimian, N., Erythropoietin receptor mRNA expression in human endothelial cells (1994) Proc. Natl. Acad. Sci. U. S. A., 91, pp. 3974-3978 | ||
| 504 | |a Arcasoy, M.O., The non-haematopoietic biological effects of erythropoietin (2008) Br. J. Haematol., 141, pp. 14-31 | ||
| 504 | |a Bennis, Y., Guillet, B., Pellegrini, L., Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential (2012) J. Thromb. Haemost., 10, pp. 1914-1928 | ||
| 504 | |a Callero, M.A., Pérez, G.M., Vittori, D.C., Vota, D.M., Pregi, N., Nesse, A.B., Modulation of protein tyrosine phosphatase 1 B by erythropoietin in UT-7 cell line (2007) Cell. Physiol. Biochem., 20, pp. 319-328 | ||
| 504 | |a Chamorro, M.E., Wenker, S.D., Vota, D.M., Vittori, D.C., Nesse, A.B., Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative (2013) Biochim. Biophys. Acta − Mol. Cell Res., 1833, pp. 1960-1968 | ||
| 504 | |a Chamorro, M.E., Maltaneri, R.E., Vittori, D.C., Nesse, A.B., Protein tyrosine phosphatase 1 B (PTP1B) is involved in the defective erythropoietic function of carbamylated erythropoietin (2015) Int. J. Biochem. Cell Biol., 61, pp. 63-71 | ||
| 504 | |a Chateauvieux, S., Grigorakaki, C., Morceau, F., Dicato, M., Diederich, M., Erythropoietin, erythropoiesis and beyond (2011) Biochem. Pharmacol., 82, pp. 1291-1303 | ||
| 504 | |a Chattopadhyay, A., Choudhury, T.D., Bandyopadhyay, D., Datta, A.G., Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical (2000) Biochem. Pharmacol., 59, pp. 419-425 | ||
| 504 | |a Chu, X., Tong, Q., Cheung, J.Y., Wozney, J., Conrad, K., Mazack, V., Interaction of TRPC2 and TRPC6 in erythropoietin modulation of calcium influx (2004) J. Biol. Chem., 279, pp. 10514-10522 | ||
| 504 | |a Coleman, T.R., Westenfelder, C., Tögel, F.E., Yang, Y., Hu, Z., Swenson, L., Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities (2006) Proc. Natl. Acad. Sci. U. S. A., 103, pp. 5965-5970 | ||
| 504 | |a Colotta, F., Bussolino, F., Polentarutti, N., Guglielmetti, A., Sironi, M., Bocchietto, E., Differential expression of the common β and specific α chains of the receptors for GM-CSF, IL-3, and IL-5 in endothelial cells (1993) Exp. Cell Res., 206, pp. 311-317 | ||
| 504 | |a De Beuf, A., Hou, X., Haese, P., Verhulst, A., Epoetin delta reduces oxidative stress in primary human renal tubular cells (2010) J. Biomed. Biotechnol., 2010, p. 395785 | ||
| 504 | |a Du, G., Zhu, H., Yu, P., Wang, H., He, J., Ye, L., SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways (2013) Eur. J. Pharmacol., 700, pp. 173-180 | ||
| 504 | |a Edgell, C.J., McDonald, C.C., Graham, J.B., Permanent cell line expressing human factor VIII-related antigen established by hybridization (1983) Proc. Natl. Acad. Sci. U. S. A., 80, pp. 3734-3737 | ||
| 504 | |a Ergul, A., Alhusban, A., Fagan, S.C., Angiogenesis a harmonized target for recovery after stroke (2012) Stroke, 43, pp. 2270-2274 | ||
| 504 | |a Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C., Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability (2001) Proc. Natl. Acad. Sci. U. S. A., 98, pp. 2604-2609 | ||
| 504 | |a Ge, R., Tai, Y., Sun, Y., Zhou, K., Yang, S., Cheng, T., Critical role of TRPC6 channels in VEGF-mediated angiogenesis (2009) Cancer Lett., 283, pp. 43-51 | ||
| 504 | |a Giannone, G., Rondé, P., Gaire, M., Beaudouin, J., Haiech, J., Ellenberg, J., Calcium rises locally trigger focal adhesion disassembly and enhance residency of focal adhesion kinase at focal adhesions (2004) J. Biol. Chem., 279, pp. 28715-28723 | ||
| 504 | |a Heeschen, C., Aicher, A., Lehmann, R., Fichtlscherer, S., Vasa, M., Urbich, C., Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization (2003) Blood, 102, pp. 1340-1346 | ||
| 504 | |a Heikal, L., Ghezzi, P., Mengozzi, M., Stelmaszczuk, B., Feelisch, M., Ferns, G.A., Erythropoietin and a nonerythropoietic peptide analog promote aortic endothelial cell repair under hypoxic conditions: role of nitric oxide (2016) Hypoxia, 4, pp. 121-133 | ||
| 504 | |a Imamura, R., Okumi, M., Isaka, Y., Ichimaru, N., Moriyama, T., Imai, E., Carbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injury (2008) Cell Transplant., 17, pp. 135-141 | ||
| 504 | |a Laemmli, U.K., Cleavage of structural protein during the assembly for the head of bacteriophage T4 (1970) Nature, 227, pp. 680-685 | ||
| 504 | |a Lanahan, A.A., Lech, D., Dubrac, A., Zhang, J., Zhuang, Z.W., Eichmann, A., PTP1b is a physiologic regulator of vascular endothelial growth factor signaling in endothelial cells (2014) Circulation, 130, pp. 902-909 | ||
| 504 | |a Lee, S.R., Kwon, K.S., Kim, S.R., Rhee, S.G., Reversible inactivation of protein-tyrosine phosphatase 1 B in A431 cells stimulated with epidermal growth factor (1998) J. Biol. Chem., 273, pp. 15366-15372 | ||
| 504 | |a Leist, M., Derivatives of erythropoietin that are tissue protective but not erythropoietic (2004) Science, 305, pp. 239-242 | ||
| 504 | |a Masuda, S., Nagao, M., Takahata, K., Konishi, Y., Gallyas, F., Jr., Tabira, T., Functional erythropoietin receptor of the cells with neural characteristics: comparison with receptor properties of erythroid cells (1993) J. Biol. Chem., 268, pp. 11208-11216 | ||
| 504 | |a Maurice, T., Mustafa, M.-H., Desrumaux, C., Keller, E., Naert, G., García-Barceló, M., Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ25-35 non-transgenic mouse model of Alzheimerós disease (2013) J. Psychopharmacol., 27, pp. 1044-1057 | ||
| 504 | |a McKinney, M., Arcasoy, M.O., Erythropoietin for oncology supportive care (2011) Exp. Cell Res., 317, pp. 1246-1254 | ||
| 504 | |a Miller, B.A., Scaduto, R.C., Jr., Tillotson, D.L., Botti, J.J., Cheung, J.Y., Erythropoietin stimulates a rise in intracellular free calcium concentration in single early human erythroid precursors (1988) J. Clin. Invest., 82, pp. 309-315 | ||
| 504 | |a Moon, C., Krawczyk, M., Paik, D., Coleman, T., Brines, M., Juhaszova, M., Erythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective properties (2006) J. Pharmacol. Exp. Ther., 316, pp. 999-1005 | ||
| 504 | |a Nakamura, Y., Patrushev, N., Inomata, H., Mehta, D., Urao, N., Kim, H.W., Role of protein tyrosine phosphatase 1 B in vascular endothelial growth factor signaling and cell?cell adhesions in endothelial cells (2008) Circ. Res., 102, pp. 1182-1191 | ||
| 504 | |a Ramirez, R., Carracedo, J., Nogueras, S., Buendia, P., Merino, A., Cañadillas, S., Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis (2009) J. Mol. Cell. Cardiol., 47, pp. 781-788 | ||
| 504 | |a Ribatti, D., Presta, M., Vacca, A., Ria, R., Giuliani, R., Dell'Era, P., Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo (1999) Blood, 93, pp. 2627-2636 | ||
| 504 | |a p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells (1997) Oncogene, 15, pp. 2169-2177 | ||
| 504 | |a Santhanam, A.V.R., Smith, L., Nath, K., Katusic, Z.S., In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries (2006) Am. J. Physiol. Heart Circ. Physiol., 291, pp. H781-H786 | ||
| 504 | |a Sautina, L., Sautin, Y., Beem, E., Zhou, Z., Schuler, A., Brennan, J., Induction of nitric oxide by erythropoietin is mediated by the β common receptor and requires interaction with VEGF receptor 2 (2010) Blood, 115, pp. 896-905 | ||
| 504 | |a Schmidt, R., Green, K., Feng, D., Dorsey, D., Parvin, C., Lee, J., Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice (2008) Exp. Neurol., 209, pp. 161-170 | ||
| 504 | |a Su, K., Shyue, S., Kou, Y., Ching, L., Chiang, A., Yu, Y., β common receptor integrates the erythropoietin signaling in activation of endothelial nitric oxide synthase (2011) J. Cell. Physiol., 226, pp. 3330-3339 | ||
| 504 | |a Toba, H., Kojima, Y., Wang, J., Noda, K., Tian, W., Kobara, M., Erythropoietin attenuated vascular dysfunction and inflammation by inhibiting NADPH oxidase-derived superoxide production in nitric oxide synthase-inhibited hypertensive rat aorta (2012) Eur. J. Pharmacol., 691, pp. 190-197 | ||
| 504 | |a Tong, Q., Hirschler-Laszkiewicz, I., Zhang, W., Conrad, K., Neagley, D.W., Barber, D.L., TRPC3 is the erythropoietin-regulated calcium channel in human erythroid cells (2008) J. Biol. Chem., 283, pp. 10385-10395 | ||
| 504 | |a Vagnucci, A.H., Li, W.W., Alzheimer's disease and angiogenesis (2003) Lancet, 361, pp. 605-608 | ||
| 504 | |a Villa, P., van Beek, J., Larsen, A.K., Gerwien, J., Christensen, S., Cerami, A., Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives (2007) J. Cereb. Blood Flow Metab., 27, pp. 552-563 | ||
| 504 | |a Vogel, V., Kramer, H.J., Bäcker, A., Meyer-Lehnert, H., Jelkmann, W., Fandrey, J., Effects of erythropoietin on endothelin-1 synthesis and the cellular calcium messenger system in vascular endothelial cells (1997) Am. J. Hypertens, 10, pp. 289-296 | ||
| 504 | |a Wang, Y., Zang, Q.S., Liu, Z., Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species (2011) Am. J. Physiol. Cell Physiol., 301, pp. C695-C704 | ||
| 504 | |a Xiong, Y., Mahmood, A., Zhang, Y., Meng, Y., Zhang, Z., Qu, C., Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury (2011) J. Neurosurg., 114, pp. 549-559 | ||
| 504 | |a Zafarullah, M., Li, W.Q., Sylvester, J., Ahmad, M., Molecular mechanisms of N-acetylcysteine actions (2003) Cell. Mol. Life Sci., 60, pp. 6-20 | ||
| 536 | |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas | ||
| 536 | |a Detalles de la financiación: Universidad de Buenos Aires | ||
| 536 | |a Detalles de la financiación: Secretaría de Ciencia y Técnica, Universidad de Buenos Aires | ||
| 536 | |a Detalles de la financiación: Our work was supported by the Universidad de Buenos Aires (UBACYT), the Consejo Nacional de Investigaciones Cient?ficas y T?cnicas (CONICET) and the Agencia Nacional de Promoci?n Cient?fica y Tecnol?gica (ANPCYT). The authors are grateful to Zelltek S.A. (Argentina) for supplying human recombinant erythropoietin. Dr. Alcira Nesse, Dr. Daniela Vittori and Dr. Mar?a E. Chamorro are research scientists at the CONICET, and Lic. Romina Maltaneri and Lic. Agustina Schiappacasse have received fellowships from the CONICET (Argentina). | ||
| 593 | |a Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Instituto del Departamento de Química Biológica de la Facultad de Ciencias Exactas y Naturales (IQUIBICEN), Departamento de Química Biológica, Facultad de Ciencias Exactas y NaturalesBuenos Aires, Argentina | ||
| 690 | 1 | 0 | |a CARBAMYLATED ERYTHROPOIETIN |
| 690 | 1 | 0 | |a CELL MIGRATION |
| 690 | 1 | 0 | |a EA.HY926 ENDOTHELIAL CELLS |
| 690 | 1 | 0 | |a ERYTHROPOIETIN |
| 690 | 1 | 0 | |a CALCIUM |
| 690 | 1 | 0 | |a CARBAMYLATED ERYTHROPOIETIN |
| 690 | 1 | 0 | |a ERYTHROPOIETIN |
| 690 | 1 | 0 | |a ERYTHROPOIETIN RECEPTOR |
| 690 | 1 | 0 | |a NITRIC OXIDE |
| 690 | 1 | 0 | |a PROTEIN TYROSINE PHOSPHATASE 1B |
| 690 | 1 | 0 | |a REACTIVE OXYGEN METABOLITE |
| 690 | 1 | 0 | |a RECOMBINANT ERYTHROPOIETIN |
| 690 | 1 | 0 | |a UNCLASSIFIED DRUG |
| 690 | 1 | 0 | |a CARBAMYLATED ERYTHROPOIETIN |
| 690 | 1 | 0 | |a ERYTHROPOIETIN |
| 690 | 1 | 0 | |a NITRIC OXIDE |
| 690 | 1 | 0 | |a PROTEIN TYROSINE PHOSPHATASE 1B |
| 690 | 1 | 0 | |a PTPN1 PROTEIN, HUMAN |
| 690 | 1 | 0 | |a REACTIVE OXYGEN METABOLITE |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a CALCIUM SIGNALING |
| 690 | 1 | 0 | |a CARBAMOYLATION |
| 690 | 1 | 0 | |a CELL CYCLE PROGRESSION |
| 690 | 1 | 0 | |a CELL MIGRATION |
| 690 | 1 | 0 | |a CELL PROLIFERATION |
| 690 | 1 | 0 | |a CONTROLLED STUDY |
| 690 | 1 | 0 | |a DRUG EFFECT |
| 690 | 1 | 0 | |a ENDOTHELIUM CELL |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a HUMAN CELL |
| 690 | 1 | 0 | |a ANALOGS AND DERIVATIVES |
| 690 | 1 | 0 | |a CELL CYCLE |
| 690 | 1 | 0 | |a CELL MOTION |
| 690 | 1 | 0 | |a COMPARATIVE STUDY |
| 690 | 1 | 0 | |a CYTOLOGY |
| 690 | 1 | 0 | |a DOSE RESPONSE |
| 690 | 1 | 0 | |a METABOLISM |
| 690 | 1 | 0 | |a UMBILICAL VEIN ENDOTHELIAL CELL |
| 690 | 1 | 0 | |a CALCIUM SIGNALING |
| 690 | 1 | 0 | |a CELL CYCLE |
| 690 | 1 | 0 | |a CELL MOVEMENT |
| 690 | 1 | 0 | |a CELL PROLIFERATION |
| 690 | 1 | 0 | |a DOSE-RESPONSE RELATIONSHIP, DRUG |
| 690 | 1 | 0 | |a ERYTHROPOIETIN |
| 690 | 1 | 0 | |a HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a NITRIC OXIDE |
| 690 | 1 | 0 | |a PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1 |
| 690 | 1 | 0 | |a REACTIVE OXYGEN SPECIES |
| 700 | 1 | |a Chamorro, M.E. | |
| 700 | 1 | |a Schiappacasse, A. | |
| 700 | 1 | |a Nesse, A.B. | |
| 700 | 1 | |a Vittori, D.C. | |
| 773 | 0 | |d Elsevier Ltd, 2017 |g v. 85 |h pp. 25-34 |p Int. J. Biochem. Cell Biol. |x 13572725 |w (AR-BaUEN)CENRE-5218 |t International Journal of Biochemistry and Cell Biology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011818888&doi=10.1016%2fj.biocel.2017.01.013&partnerID=40&md5=73495c064cdc0b223fd95768c9e85bb8 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.biocel.2017.01.013 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_13572725_v85_n_p25_Maltaneri |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_13572725_v85_n_p25_Maltaneri |y Registro en la Biblioteca Digital |
| 961 | |a paper_13572725_v85_n_p25_Maltaneri |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 76026 | ||